This is not your mate.
Novartis' drug Exelon with $420m sales was the main source of income for Hebrew University's in 2004.
University's researchers receive 40% of royalties from patents and 20% of the revenues for their labs. #patents /4
Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!
Support us! We are indie developers!
This site is made by just three indie developers on a laptop doing marketing, support and development! Read more about the story.
Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!
Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)Donate via Paypal Become our Patreon
Thank you for your support!